| TCF-1 regulates HIV-specific CD8+ T cell expansion capacity RL Rutishauser, CDT Deguit, J Hiatt, F Blaeschke, TL Roth, L Wang, ... JCI insight 6 (3), 2021 | 47 | 2021 |
| FOXO1 promotes HIV latency by suppressing ER stress in T cells A Vallejo-Gracia, IP Chen, R Perrone, E Besnard, D Boehm, E Battivelli, ... Nature microbiology 5 (9), 1144-1157, 2020 | 20 | 2020 |
| APOBEC3F is a mutational driver of the human Monkeypox virus identified in the 2022 outbreak R Suspène, KA Raymond, L Boutin, S Guillier, F Lemoine, O Ferraris, ... The Journal of Infectious Diseases 228 (10), 1421-1429, 2023 | 11 | 2023 |
| Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response P Khalfi, R Suspène, KA Raymond, V Caval, G Caignard, N Berry, ... PLoS Pathogens 19 (2), e1011170, 2023 | 5 | 2023 |
| TCF-1 regulates the stem-like memory potential of HIV-specific CD8+ T cells in elite controllers RL Rutishauser, CDT Deguit, J Hiatt, F Blaeschke, TL Roth, L Wang, ... bioRxiv, 2020.01. 07.894535, 2020 | 5 | 2020 |
| The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency HS Sperber, KA Raymond, MS Bouzidi, T Ma, S Valdebenito, EA Eugenin, ... Cell reports 42 (11), 2023 | 3 | 2023 |
| APOBEC3F is the main source of editing identified during the 2022 outbreak of human monkeypox virus R Suspène, KA Raymond, L Boutin, S Guillier, F Lemoine, O Ferraris, ... bioRxiv, 2023.01. 06.522979, 2023 | 3 | 2023 |
| μ-Lat: a mouse model to evaluate human immunodeficiency virus eradication strategies HS Sperber, PP Togarrati, KA Raymond, MS Bouzidi, R Gilfanova, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 2 | 2020 |
| The APOBEC3B cytidine deaminase is an adenovirus restriction factor N Lejeune, S Mathieu, A Decloux, F Poulain, Z Blockx, KA Raymond, ... PLoS Pathogens 19 (2), e1011156, 2023 | 1 | 2023 |
| High-resolution Inference of Multiplexed Anti-HIV Gene Editing using Single-Cell Targeted DNA Sequencing MS Bouzidi, ZY Dossani, C Di Benedetto, KA Raymond, S Desai, ... bioRxiv, 2024 | | 2024 |
| MAJOR ARTICLE R Suspène, KA Raymond, L Boutin, S Guillier, F Lemoine, O Ferraris, ... | | 2023 |
| Single-Cell Inference of CRISPR-Cas9-Mediated Antiviral Gene Editing in HIV-Infected Microglia MS Bouzidi, ZY Dossani, J Hiatt, HS Sperber, L Du, KA Raymond, ... MOLECULAR THERAPY 29 (4), 333-334, 2021 | | 2021 |
| Durable Control of HIV-1 Using a Staphylococcus aureus Cas9-Expressing Lentivirus Co-Targeting Viral Latency and Host Susceptibility LR Chavez, NR Reddy, KA Raymond, MS Bouzidi, S Desai, ZY Dossani, ... bioRxiv, 2020.08. 10.243329, 2020 | | 2020 |
| μ-Lat: a high-throughput humanised mouse model of latent HIV infection H Sperber, PP Togarrati, K Raymond, MS Bouzidi, R Gilfanova, ... | | 2019 |
